Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

$IMRX stock is up 13% today. Here's what we see in our data.

None

$IMRX stock has now risen 13% today, according to our price data from Polygon. There has been approximately $10,974,490 of trading volume.

It has been the 464th most-searched ticker on Quiver Quantitative over the last day, out of 14,304 total tickers searched.

Here is what we see in our data on $IMRX (you can track the company live on Quiver's $IMRX stock page):

$IMRX Insider Trading Activity

IMRX Insider Trades

$IMRX insiders have traded $IMRX stock on the open market 5 times in the past 6 months. Of those trades, 5 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $IMRX stock by insiders over the last 6 months:

  • THOMAS J. SCHALL purchased 21,645 shares for an estimated $101,041
  • PETER FEINBERG purchased 20,000 shares for an estimated $86,904
  • HAROLD EUGENE BRAKEWOOD (Chief Business Officer) purchased 5,250 shares for an estimated $24,990
  • LEAH R NEUFELD (CHIEF PEOPLE OFFICER) purchased 2,626 shares for an estimated $10,905
  • BRETT MATTHEW HALL (CHIEF SCIENTIFIC OFFICER) purchased 2,298 shares for an estimated $10,501

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$IMRX Hedge Fund Activity

We have seen 58 institutional investors add shares of $IMRX stock to their portfolio, and 50 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$IMRX Analyst Ratings

Wall Street analysts have issued reports on $IMRX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Chardan Capital issued a "Buy" rating on 05/19/2026

To track analyst ratings and price targets for $IMRX, check out Quiver Quantitative's $IMRX forecast page.

$IMRX Price Targets

Multiple analysts have issued price targets for $IMRX recently. We have seen 2 analysts offer price targets for $IMRX in the last 6 months, with a median target of $15.5.

Here are some recent targets:

  • Geulah Livshits from Chardan Capital set a target price of $20.0 on 05/19/2026
  • Ami Fadia from Needham set a target price of $11.0 on 03/09/2026

You can track data on $IMRX on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles